192 related articles for article (PubMed ID: 1733777)
1. Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.
Andreu D; Ubach J; Boman A; Wåhlin B; Wade D; Merrifield RB; Boman HG
FEBS Lett; 1992 Jan; 296(2):190-4. PubMed ID: 1733777
[TBL] [Abstract][Full Text] [Related]
2. Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids.
Boman HG; Wade D; Boman IA; Wåhlin B; Merrifield RB
FEBS Lett; 1989 Dec; 259(1):103-6. PubMed ID: 2689223
[TBL] [Abstract][Full Text] [Related]
3. Antibacterial peptides designed as analogs or hybrids of cecropins and melittin.
Wade D; Andreu D; Mitchell SA; Silveira AM; Boman A; Boman HG; Merrifield RB
Int J Pept Protein Res; 1992 Nov; 40(5):429-36. PubMed ID: 1483838
[TBL] [Abstract][Full Text] [Related]
4. Structure-antibacterial, antitumor and hemolytic activity relationships of cecropin A-magainin 2 and cecropin A-melittin hybrid peptides.
Shin SY; Kang JH; Hahm KS
J Pept Res; 1999 Jan; 53(1):82-90. PubMed ID: 10195445
[TBL] [Abstract][Full Text] [Related]
5. Hydrophobic effects on antibacterial and channel-forming properties of cecropin A-melittin hybrids.
Juvvadi P; Vunnam S; Merrifield EL; Boman HG; Merrifield RB
J Pept Sci; 1996; 2(4):223-32. PubMed ID: 9231329
[TBL] [Abstract][Full Text] [Related]
6. Retro and retroenantio analogs of cecropin-melittin hybrids.
Merrifield RB; Juvvadi P; Andreu D; Ubach J; Boman A; Boman HG
Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3449-53. PubMed ID: 7724582
[TBL] [Abstract][Full Text] [Related]
7. All-D amino acid-containing channel-forming antibiotic peptides.
Wade D; Boman A; Wåhlin B; Drain CM; Andreu D; Boman HG; Merrifield RB
Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4761-5. PubMed ID: 1693777
[TBL] [Abstract][Full Text] [Related]
8. Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii.
Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Del Prete MS; Łukasiak J; Scalise G
Peptides; 2003 Sep; 24(9):1315-8. PubMed ID: 14706545
[TBL] [Abstract][Full Text] [Related]
9. NMR structural characterization of cecropin A(1-8) - magainin 2(1-12) and cecropin A (1-8) - melittin (1-12) hybrid peptides.
Oh D; Shin SY; Kang JH; Hahm KS; Kim KL; Kim Y
J Pept Res; 1999 May; 53(5):578-89. PubMed ID: 10424354
[TBL] [Abstract][Full Text] [Related]
10. Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii.
Rodríguez-Hernández MJ; Saugar J; Docobo-Pérez F; de la Torre BG; Pachón-Ibáñez ME; García-Curiel A; Fernández-Cuenca F; Andreu D; Rivas L; Pachón J
J Antimicrob Chemother; 2006 Jul; 58(1):95-100. PubMed ID: 16636085
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and study of normal, enantio, retro, and retroenantio isomers of cecropin A-melittin hybrids, their end group effects and selective enzyme inactivation.
Vunnam S; Juvvadi P; Rotondi KS; Merrifield RB
J Pept Res; 1998 Jan; 51(1):38-44. PubMed ID: 9495589
[TBL] [Abstract][Full Text] [Related]
12. Activities of polymyxin B and cecropin A-,melittin peptide CA(1-8)M(1-18) against a multiresistant strain of Acinetobacter baumannii.
Saugar JM; Alarcón T; López-Hernández S; López-Brea M; Andreu D; Rivas L
Antimicrob Agents Chemother; 2002 Mar; 46(3):875-8. PubMed ID: 11850277
[TBL] [Abstract][Full Text] [Related]
13. N-terminal analogues of cecropin A: synthesis, antibacterial activity, and conformational properties.
Andreu D; Merrifield RB; Steiner H; Boman HG
Biochemistry; 1985 Mar; 24(7):1683-8. PubMed ID: 3924096
[TBL] [Abstract][Full Text] [Related]
14. D-enantiomers of 15-residue cecropin A-melittin hybrids.
Merrifield EL; Mitchell SA; Ubach J; Boman HG; Andreu D; Merrifield RB
Int J Pept Protein Res; 1995; 46(3-4):214-20. PubMed ID: 8537174
[TBL] [Abstract][Full Text] [Related]
15. Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action.
Saugar JM; Rodríguez-Hernández MJ; de la Torre BG; Pachón-Ibañez ME; Fernández-Reyes M; Andreu D; Pachón J; Rivas L
Antimicrob Agents Chemother; 2006 Apr; 50(4):1251-6. PubMed ID: 16569836
[TBL] [Abstract][Full Text] [Related]
16. Two-dimensional proton-NMR studies on a hybrid peptide between cecropin A and melittin. Resonance assignments and secondary structure.
Sipos D; Chandrasekhar K; Arvidsson K; Engström A; Ehrenberg A
Eur J Biochem; 1991 Jul; 199(2):285-91. PubMed ID: 2070788
[TBL] [Abstract][Full Text] [Related]
17. Permeabilization of the mitochondrial inner membrane by short cecropin-A-melittin hybrid peptides.
Díaz-Achirica P; Prieto S; Ubach J; Andreu D; Rial E; Rivas L
Eur J Biochem; 1994 Aug; 224(1):257-63. PubMed ID: 8076647
[TBL] [Abstract][Full Text] [Related]
18. Conformation of the cecropin-melittin hybrid, cecropin A(1-8)-melittin (1-18) antibacterial Peptide.
Tauro S; Coutinho E; Srivastava S
Protein Pept Lett; 2004 Apr; 11(2):115-24. PubMed ID: 15078199
[TBL] [Abstract][Full Text] [Related]
19. Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria.
Piers KL; Brown MH; Hancock RE
Gene; 1993 Nov; 134(1):7-13. PubMed ID: 8244033
[TBL] [Abstract][Full Text] [Related]
20. Structure-antitumor and hemolytic activity relationships of synthetic peptides derived from cecropin A-magainin 2 and cecropin A-melittin hybrid peptides.
Shin SY; Lee MK; Kim KL; Hahm KS
J Pept Res; 1997 Oct; 50(4):279-85. PubMed ID: 9352466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
